Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study.
The Internet Journal of Asthma, Allergy and Immunology · 2011
DOI: 10.5580/22b1 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Internet Journal of Asthma, Allergy and Immunology, 2011.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2011). Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study. The Internet Journal of Asthma, Allergy and Immunology. https://doi.org/10.5580/22b1
Vancouver
Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study. The Internet Journal of Asthma, Allergy and Immunology. 2011. doi:10.5580/22b1
BibTeX
@article{euvimed2011,
title = {Efficacy And Safety Evaluation Of A Dry Powder Inhaler Containing Salmeterol Xinafoate 25 Mcg/Fluticasone Propionate 250 Mcg In Subjects With Asthma: A Randomized, Open Label, Comparative, Active Controlled, Parallel Groups, And Multi-Centric Study},
journal = {The Internet Journal of Asthma, Allergy and Immunology},
year = {2011},
doi = {10.5580/22b1}
}
EUVIMED